At DC Circ., Pharma's Latest Pricing Loss Has Silver Linings
The pharmaceutical industry's far-flung crusade against Medicare's new negotiation powers suffered a fresh setback Tuesday as the D.C. Circuit joined sister circuits in upholding the landmark pricing program, but the defeat...To view the full article, register now.
Already a subscriber? Click here to view full article